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Treatment of a primary type IA endoleak with a
liquid embolic system under conditions of aortic
occlusion
Lem Kirby, MD,a and John Goodwin, MD,b Knoxville, Tenn
We present the case of a primary type IA endoleak after deployment of a bifurcated Ancure endograft (Guidant
Endovascular Solutions, Menlo Park, Calif) to treat a 9-cm abdominal aortic aneurysm with a short angulated neck. The
endoleak was treated unsuccessfully with repeat balloon angioplasty, placement of a Palmaz aortic stent (Cordis
Endovascular, Miami, Fla), and deployment of an AneuRx aortic extender cuff (Medtronic AneuRx, Santa Rosa, Calif).
The endoleak then was sealed with injection of n-butyl cyanoacrylate into the aneurysm sac at the site of the leak with
occlusion of aortic flow. We suggest the use of this liquid embolic agent be considered as an adjunct to control primary
type IA endoleaks when other forms of therapy have failed. (J Vasc Surg 2003;37:456-60.)
Endovascular repair of abdominal aortic aneurysm
(AAA) has become an acceptable alternative to open aneu-
rysm repair. Endoleak, the persistence of blood flow out-
side the endograft but within the aneurysm sac, continues
to complicate this approach.1 The incidence rate of en-
doleak is reported to range from 5% to 47%, of which one
half may resolve without intervention.2 Endoleaks that
occur during the perioperative period (30 days) are termed
primary, whereas those occurring after the 30-day operative
period are termed secondary. Endoleaks have been classi-
fied into four major types. Type I endoleaks are the result of
blood flow around the proximal (type IA) or distal (type
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Fig 1. A, Preoperative aortogram shows aneurysm’s short (13-mm) and angulated (75-degree) neck. B, Intraoper-
ative aortogram shows left posterolateral type IA endoleak. Arrows outline endoleak’s location. C, Intraoperative
aneurysm sacogram shows endoleak. D, Intraoperative completion aortogram shows location of n-BCA (arrows) and
aneurysm exclusion. Notice that n-BCA fills area within aneurysm sac corresponding to sacogram, including site of
endoleak’s origin (left posterolateral).
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IB) attachment sites of the endograft. Type II leaks repre-
sent continued perfusion of the aneurysm sac via retrograde
flow through aortic side branches. Type III leaks occur at
the junction points of modular grafts or at a tear in the
graft’s fabric. Type IV leaks represent transgraft flow.3,4
Type I endoleaks are high-pressure leaks, representing a
failure of stent graft therapy that must be treated to prevent
aneurysm rupture.5 In this case report, we present a primary
type IA endoleak that was successfully treated with the
TRUFILL n-butyl cyanoacrylate liquid embolic system
(TRUFILL n-BCA, Cordis Neurovascular, Miami, Fla)
under conditions of aortic occlusion.
CASE REPORT
A 76-year-old man was seen in the emergency department
with severe acute pancreatitis, choledocholithiasis, and bilateral
lobar pneumonia. Initial work-up included a computed tomo-
graphic (CT) scan of the abdomen and pelvis that revealed a 9-cm
AAA. After resolution of the pancreatitis and improvement of
pulmonary status, the patient underwent successful endoscopic
retrograde cholangiopancreatography to clear the common bile
duct.
The patient was quite debilitated and continued to have a
tender abdomen in the face of a 9-cm AAA. Because of this, despite
the unfavorable aortic anatomy, an endovascular approach for
aneurysm repair was recommended. Preoperative angiography and
CT scan revealed an angulated (75-degree) proximal neck with a
diameter of 24 mm and a length of 13 mm (Fig 1, A).
A 26-mm  13-mm  17-cm Ancure bifurcated endograft
(Guidant Endovascular Solutions, Menlo Park, Calif) was placed.
The limbs of the graft were stented with 14-mm  40-mm
Wallstents (Boston Scientific Vascular, Watertown, Mass) second-
ary to native iliac stenosis. Completion angiography showed a large
type IA endoleak. This was treated with repeat balloon angioplasty
of the proximal attachment system with a 25-mm  50-mm
Z-Med II aortic balloon (B Braun Medical, Inc, Bethlehem, Pa)
and delivery of a transrenal 50-mm Palmaz aortic stent (Cordis
Endovascular, Miami, Fla). Despite these maneuvers, the endoleak
remained (Fig 1, B). The procedure was terminated because of
Fig 2. Thirty-six–hour postoperative noncontrasted (A to C) and contrasted (D to F) CT scan images at three
corresponding levels. Noncontrasted images show location of endograft within aneurysm sac and highly radiopaque
n-BCA in left posterolateral location, which was site of endoleak’s origin (arrows). Noncontrasted study is important
because n-BCA could be mistaken for endoleak. Contrasted images show aneurysm exclusion.
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operative time and the need to plan for further intervention and
obtain additional materials.
The patient was returned to the endovascular suite 48 hours
later. The right femoral artery was accessed with a 7F sheath, and a
0.035-in Glidewire (Boston Scientific Microvassive, Natick, Mass)
was passed between the native common iliac artery and the limb of
the endograft. This was exchanged for a 5F angiographic catheter,
thus providing access to the aneurysm sac. Access to the endograft
was obtained with a 22F  40-cm Cook sheath (Cook, Inc,
Indianapolis, Ind). After an aortogram was performed to mark the
exact location of the renal arteries and the endoleak (left postero-
lateral), a 28-mm AneuRx aortic extender cuff (Medtronic An-
euRx, Santa Rosa, Calif) was deployed in an unsuccessful attempt
to seal the endoleak. Repeat aortic balloon angioplasty was per-
formed at this point but also failed to seal the endoleak. An
aneurysm sacogram was performed through the angiographic cath-
eter, which had been placed in the sac (Fig 1, C). Aortic sac
pressure was measured before and after aortic balloon occlusion.
Sac pressure was pulsatile and systemic before and after aortic
balloon inflation and nonpulsatile and essentially zero with aortic
balloon inflation. An Agility 16 guidewire (0.016-in, Cordis Neu-
rovascular, Miami Lakes, Fla) was advanced through the angio-
graphic catheter and exchanged for a Prowler Plus microcatheter
(Cordis Neurovascular), which was positioned posterolaterally in
the aneurysm neck at the site of the endoleak. The Z-Med II aortic
balloon then was inflated to the profile of the endograft’s proximal
attachment system, which occluded aortic and endoleak flow.
Outflow occlusion on the left was achieved with the 22F sheath,
and the right common femoral artery was clamped at the level of
the groin. The right internal iliac artery was the only patent major
outflow vessel. The TRUFILL n-BCA liquid embolic system was
prepared by mixing 4 mL of ethiodized oil with 1 mL of n-BCA.
3.5 mL of this preparation were injected through the microcath-
eter under fluoroscopic guidance using the sacogram as a road
map. The aortic balloon remained inflated for 1 minute after
completion of n-BCA injection. Angiography showed patent renal
arteries and good flow through the endograft and no apparent
endoleak (Fig 1, D).
A CT scan performed 36 hours after surgery clearly showed
the n-BCA’s location and aneurysm exclusion (Fig 2). Three days
after completion of AAA repair, the patient underwent uncompli-
cated laparoscopic cholecystectomy and was discharged home the
following day. A CT scan performed 3 months after surgery
showed no evidence of the type I endoleak and no change in the
size of the aneurysm sac. However, a type two endoleak developed
in the interim and is being followed with serial imaging (Fig 4).
DISCUSSION
Type IA endoleaks are a common cause of endograft
failure. Such leaks can occur as a result of angulation of the
aneurysm neck, a short noncircular proximal attachment
zone, mural thrombus or calcification, malposition of the
endograft during deployment, or underdilatation of the
graft material.5
Recommended techniques for repair of type IA en-
doleaks include repeat balloon angioplasty of the proximal
attachment system, use of aortic extender cuffs, and trans-
renal stent fixation.3,6 Beyond this, surgical band ligature of
the aortic neck and conversion to open aneurysm repair
have been the only options.6 Biologic glue has been used to
treat type II endoleaks, but its use to treat type I endoleaks
has never been reported.7
The TRUFILL n-BCA liquid embolic system is an
artificial embolization device made up of n-BCA and ethio-
dized oil. n-BCA is a monomer that is a free flowing liquid
that polymerizes into a solid material instantly with an
anionic mechanism when it comes into contact with body
fluids or tissue. Ethiodized oil is made up of 37% iodine
organically combined with the ethyl esters of fatty acids of
poppy seed oil. The iodine makes it radiopaque, and the oil
helps to control n-BCA polymerization. The TRUFILL
n-BCA system is US Food and Drug Administration ap-
proved for the embolization of cerebral arteriovenous mal-
formations.8
Aneurysm sacs have been thrombosed and type II
endoleaks treated with other agents, including thrombin
(Gentrac Inc, Middleton, Wis) and Gianturco coils (Cook,
Inc).9 We believe that the n-BCA embolic system offers
certain advantages over these other agents for the treatment
of type I endoleaks. The n-BCA polymerizes instantly into
a solid material that adheres to body tissues. These other
agents serve as a nidis for physiologic thrombosis, which
Fig 3. Postoperative plain film radiograph of abdomen shows
location of Ancure endograft, Palmaz aortic stent, AneuRx aortic
extender cuff, iliac Wallstents, and n-BCA (arrows).
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takes significantly longer. This time delay would be a dis-
advantage in this case because aortic (and renal artery)
occlusion is necessary. Further, the solid n-BCA polymer
likely offers the strength necessary to seal a high flow leak,
and freshly thrombosed blood probably does not. Finally,
the n-BCA system is highly radiopaque and can fill and
conform to the endoleak channel. We believe that these
properties allowed us to truly seal the endoleak channel.
Inability to precisely place liquid embolic agents in the
face of a high-pressure leak has been a major concern.
Escape of the material into the systemic circulation could
lead to thrombosis of critical vessels, such as renal, mesen-
teric, or spinal arteries, which could have devastating clini-
cal consequences. In addition, there is the potential of the
embolic agent to escape from the sac into lumbar or other
vessels emanating from the sac itself, causing spinal cord
dysfunction or other neurologic defects. We were able to
precisely place the n-BCA in this case by first gaining access
to the aneurysm sac by passing between the limb of the
aortic graft and the native iliac artery. This method of sac
access may not be achievable in many cases and may depend
on the type of endograft used, the use of stents to support
the iliac limbs, or tortuous iliac arteries. Direct sac puncture
has been well described and could be used as an alternative
approach.9 The aortic sacogram was used as a road map to
guide agent delivery, and flow into the aneurysm sac was
occluded, as described in the Case Report, to prevent
escape of the n-BCA from the target area. n-BCA injection
was performed with fluoroscopic guidance and was easy to
visualize as it filled the endoleak channel and the patent
portion of the aneurysm sac. Having a sacogram as a road
map and attaining aortic occlusion are believed to be critical
to assure exact delivery of the embolic agent.
Postembolization sac pressure measurement is impor-
tant to help assure endoleak seal and should always be
considered in cases of endoleak treatment. It was unfortu-
nately not done in this case because we removed the micro-
catheter and the angiographic catheter as a unit, thereby
losing sac access. As with all endovascular aneurysm repairs,
lifetime follow-up is mandatory. Follow-up imaging studies
including CT scan and plain film radiograph both show
glue location (Figs 2 and 3). A noncontrasted CT scan is
essential because n-BCA is very radiopaque and can be
Fig 4. Three-month postoperative CT scan. A to C, These contrasted images, at corresponding levels compared with
Fig 2, show stable aneurysm sac and no evidence of type I endoleak. D to F, These images (D, noncontrasted; E,
contrasted; and F, postcontrast) are at corresponding levels and show type II endoleak (arrow).
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mistaken for contrast extravasation consistent with an en-
doleak.
The use of n-BCA for the treatment of type IA en-
doleaks should be considered after more conventional
methods to seal the leak have failed. Because this method to
seal a type IA endoleak requires aneurysm sac access, main-
taining wire access of the sac in cases where difficulty
obtaining a proximal seal are anticipated should be consid-
ered. However, because these are often long and difficult
cases for both the surgical team and the patient, one should
not hesitate to complete treatment at a later time if the
patient is in a stable situation. The long-term success of this
method of type I endoleak repair is unknown, and the
potential for recurrent leak is certainly present. Therefore,
n-BCA embolization of type I endoleaks should not be
relied on to extend the indications for endovascular AAA
repair.
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